Discovery and development of Factor Xa inhibitors (2015–2022)
W Zheng, X Dai, B Xu, W Tian, J Shi - Frontiers in Pharmacology, 2023 - frontiersin.org
As a pathological coagulation process, thrombus can lead to many serious diseases,
including ischemic stroke, acute myocardial infarction (AMI), acute coronary syndrome …
including ischemic stroke, acute myocardial infarction (AMI), acute coronary syndrome …
LC–MS-based multivariate statistical analysis for the screening of potential thrombin/factor Xa inhibitors from Radix Salvia Miltiorrhiza
Background The dry root and rhizome of Salvia miltiorrhiza Bunge, or Danshen, is a well-
known traditional Chinese medicine with anticoagulant activity. Taking into account that …
known traditional Chinese medicine with anticoagulant activity. Taking into account that …
Fingerprint analysis of dang-gui-Si-Ni decoction and its anticoagulant activity in vivo-in vitro
Y Li, TT Ren, SS Liu, L Zhang, H Yi, C Li… - Journal of …, 2024 - Elsevier
Abstract Ethnopharmacological relevance Dang-Gui-Si-Ni (DGSN) decoction is a classic
prescription in the clinical practice of traditional Chinese Medicine (TCM). DGSN decoction …
prescription in the clinical practice of traditional Chinese Medicine (TCM). DGSN decoction …
Novel isosteviol-based FXa inhibitors: Molecular modeling, in silico design and docking simulation
Direct oral anticoagulants are an important and relatively new class of synthetic
anticoagulant drugs commonly used for the pharmacotherapy of thromboembolic disorders …
anticoagulant drugs commonly used for the pharmacotherapy of thromboembolic disorders …
Inhibitory Effect of Triterpenoids from Panax ginseng on Coagulation Factor X
L Xiong, Z Qi, B Zheng, Z Li, F Wang, J Liu, P Li - Molecules, 2017 - mdpi.com
Enzymes involved in the coagulation process have received great attention as potential
targets for the development of oral anti-coagulants. Among these enzymes, coagulation …
targets for the development of oral anti-coagulants. Among these enzymes, coagulation …
Design, synthesis and biological evaluation of piperazinylanthranilamides as potential factor Xa inhibitors
AN Khadse, HH Savsani, RV Chikhale… - Journal of Molecular …, 2022 - Elsevier
Direct inhibition of FXa has emerged as an effective strategy to achieve anticoagulation
maintaining normal hemostasis with minimal bleeding risks. A novel series of …
maintaining normal hemostasis with minimal bleeding risks. A novel series of …
Spectroscopic, DFT, and XRD Studies of Hydrogen Bonds in N-Unsubstituted 2-Aminobenzamides
The structures of the mono-and the dihalogenated N-unsubstituted 2-aminobenzamides
were characterized by means of the spectroscopic (1H-NMR, UV-Vis, FT-IR, and FT-Raman) …
were characterized by means of the spectroscopic (1H-NMR, UV-Vis, FT-IR, and FT-Raman) …
The development of new low-molecular-weight factor Xa inhibitors that are potential anticoagulants
DG Tovbin, DN Tarasov, DV Malakhov… - Current Drug …, 2022 - ingentaconnect.com
Background: Despite the introduction of direct oral anticoagulants, the search for new oral
anticoagulants remains an urgent task. Objective: By using docking and scoring, based on …
anticoagulants remains an urgent task. Objective: By using docking and scoring, based on …
An unexpected dynamic binding mode between coagulation factor X and Rivaroxaban reveals importance of flexibility in drug binding
SY Qu, Q Xu, W Wu, F Li, CD Li… - Chemical Biology & …, 2019 - Wiley Online Library
Rivaroxaban (RIV) is a direct oral anticoagulant (DOAC) targeting activated coagulation
factor X (FXa). An earlier study reported the F174A mutant of FXa resistant to a RIV‐like …
factor X (FXa). An earlier study reported the F174A mutant of FXa resistant to a RIV‐like …
Computer Design of Low-Molecular-Weight Inhibitors of Coagulation Factors
AS Kabankin, EI Sinauridze, EN Lipets… - Biochemistry …, 2019 - Springer
The review discusses main approaches to searching for new low-molecular-weight
inhibitors of coagulation factors IIa, Xa, IXa, and XIa and the results of such studies …
inhibitors of coagulation factors IIa, Xa, IXa, and XIa and the results of such studies …